Evaluation of an Interactive Mental Wellness (I-AM-WELL) Program on Final Year Nursing Students
Launched by NATIONAL UNIVERSITY OF SINGAPORE · Dec 5, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The I-AM-WELL clinical trial is studying a special online program designed to help final year nursing students improve their mental wellness. The program focuses on managing feelings like anxiety, depression, and stress, while also promoting resilience, readiness for practice, physical activity, and healthy eating habits. By participating, students will have the chance to learn how effective this program can be and share their experiences with it.
To be eligible for this study, you need to be a final year nursing student, at least 18 years old, and able to understand English. You should also have access to the internet through a device like a computer or smartphone. If you choose to participate, you will take part in the I-AM-WELL program online at your own pace. This is a great opportunity for nursing students to enhance their mental wellness while preparing for their future careers in healthcare.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Final year nursing students enrolled in the undergraduate nursing program
- • Above the ages of 18 years
- • Able to comprehend the English language
- • Have a device that can connect to the Internet
- Exclusion Criteria:
- • Students who refused to participate in the study
About National University Of Singapore
The National University of Singapore (NUS) is a leading global research university recognized for its commitment to advancing scientific knowledge and fostering innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, NUS conducts cutting-edge clinical trials aimed at addressing critical health challenges and improving patient outcomes. The university's state-of-the-art facilities, coupled with its team of renowned researchers and clinicians, enable the development and evaluation of novel therapies and interventions. NUS is dedicated to translating research findings into practical applications, ultimately enhancing the quality of care and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Darryl Ang, PhD
Principal Investigator
National University of Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported